Meet suzetrigine, a non-opioid that promises to avoid addiction risk. But some experts say it can't replace opioids ...

Biotech company Vertex Pharmaceuticals (NASDAQ:VRTX) will be reporting results tomorrow afternoon. Here’s what to look for.

Vertex Pharmaceuticals ( VRTX 2.53%) has long been known as the company to turn to for life-saving cystic fibrosis (CF) drugs ...

Sionna Therapeutics has closed its initial public offering, raising $191 million for its pipeline of therapies for cystic ...

临床阶段生命科学企业Sionna Therapeutics即将于美国纳斯达克市场挂牌上市，股票代码定为“SION”。据悉，该公司计划以每股18美元的价格发行1059万股股票，预计募集资金总额将达到1.9亿美元。 这笔资金将主要用于Sionna ...

To illustrate that point, let's discuss two stocks in the biotech industry that have moved in opposite directions so far this ...

周一，H.C. Wainwright分析师Andrew Fein将Vertex Pharmaceuticals Incorporated (NASDAQ: VRTX )的目标价从之前的535美元上调至550美元，同时维持对该股的买入评级。根据 InvestingPro ...

周五，Cantor Fitzgerald重申了对Vertex Pharmaceuticals Incorporated (NASDAQ: VRTX )的"增持"评级和480.00美元的目标价。该公司目前交易价格为438.40美元，市值为1129亿美元。该公司分析师Olivia Brayer讨论了公司最近在其治疗方法上获得广泛标签的成就，引发了对潜在定价策略的疑问。根据 InvestingPro ...

2025-01-31 07:43发布于江苏药明康德官方账号 刚刚，美国FDA宣布批准Vertex ...

Financial giants have made a conspicuous bearish move on Vertex Pharmaceuticals. Our analysis of options history for Vertex ...

Shares of Vertex Pharmaceuticals Inc. surged ahead of Friday’s market open after the Food and Drug Administration approved ...

Despite high demand for an option like Journavx, doctors fear the drug’s price could be a hangup for insurers and limit ...